NDC 0469-1602

Vaprisol

Conivaptan Hydrochloride

Vaprisol is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Conivaptan Hydrochloride.

• Product ID: 0469-1602_cc0b0c1e-18f6-42cc-8fcb-81fa4e74e5a8
• NDC: 0469-1602
• Product Type: Human Prescription Drug
• Proprietary Name: Vaprisol
• Generic Name: Conivaptan Hydrochloride
• Dosage Form: Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2008-10-08
• Marketing Category: NDA /
• Application Number: NDA021697
• Labeler Name: Astellas Pharma US, Inc.
• Substance Name: CONIVAPTAN HYDROCHLORIDE
• Active Ingredient Strength: 20 mg/100mL
• Pharm Classes: Cytochrome P450 3A Inhibitors [MoA], Vasopressin Receptor Antagonist [EPC], Vasopressin Receptor Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC SPL Data Element Entries

NDC 0469-1602-10 [00469160210]

Vaprisol SOLUTION

• Marketing Category: NDA
• Application Number: NDA021697
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2010-06-07
• Marketing End Date: 2014-02-27

NDC 0469-1602-11 [00469160211]

Vaprisol SOLUTION

• Marketing Category: NDA
• Application Number: NDA021697
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2008-10-08
• Marketing End Date: 2011-03-01

Drug Details

NDC Crossover Matching brand name "Vaprisol" or generic name "Conivaptan Hydrochloride"

NDC	Brand Name	Generic Name
0469-1602	Vaprisol	conivaptan hydrochloride
66220-160	VAPRISOL DEXTROSE IN PLASTIC CONTAINER	conivaptan hydrochloride